PUFA stabilizes a conductive state of the selectivity filter in IKs channelsShow others and affiliations
2024 (English)In: eLIFE, E-ISSN 2050-084X, Vol. 13, article id RP95852
Article in journal (Refereed) Published
Abstract [en]
In cardiomyocytes, the KCNQ1/KCNE1 channel complex mediates the slow delayed-rectifier current (IKs), pivotal during the repolarization phase of the ventricular action potential. Mutations in IKs cause long QT syndrome (LQTS), a syndrome with a prolonged QT interval on the ECG, which increases the risk of ventricular arrhythmia and sudden cardiac death. One potential therapeutical intervention for LQTS is based on targeting IKs channels to restore channel function and/or the physiological QT interval. Polyunsaturated fatty acids (PUFAs) are potent activators of KCNQ1 channels and activate IKs channels by binding to two different sites, one in the voltage sensor domain - which shifts the voltage dependence to more negative voltages - and the other in the pore domain - which increases the maximal conductance of the channels (Gmax). However, the mechanism by which PUFAs increase the Gmax of the IKs channels is still poorly understood. In addition, it is unclear why IKs channels have a very small single-channel conductance and a low open probability or whether PUFAs affect any of these properties of IKs channels. Our results suggest that the selectivity filter in KCNQ1 is normally unstable, contributing to the low open probability, and that the PUFA-induced increase in Gmax is caused by a stabilization of the selectivity filter in an open-conductive state.
Place, publisher, year, edition, pages
eLIFE SCIENCES PUBL LTD , 2024. Vol. 13, article id RP95852
Keywords [en]
arrhythmia; IKs channel; PUFA; single channels; long QT syndrome; selectivity filter
National Category
Medical Biotechnology (Focus on Cell Biology, (incl. Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
URN: urn:nbn:se:liu:diva-211218DOI: 10.7554/eLife.95852ISI: 001394446200001PubMedID: 39480699Scopus ID: 2-s2.0-85208290409OAI: oai:DiVA.org:liu-211218DiVA, id: diva2:1931957
Note
Funding Agencies|National Heart, Lung, and Blood Institute [5R01HL131461]; Heart and Stroke Foundation of Canada [G-21-0031566]; Canadian Institutes of Health Research [PJT-180245 D, PJT-175024]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2022-03021]; Canada Research Chairs D Peter Tieleman
2025-01-282025-01-282025-05-14